Imago BioSciences

About:

Imago is a clinical stage biopharmaceutical company that develops drugs for the management of proliferative diseases of the bone marrow.

Website: http://imagobio.com/

Twitter/X: imagobiorx

Top Investors: BlackRock, MRL Ventures Fund, T. Rowe Price, Pharmaron, Surveyor Capital

Description:

Imago BioSciences is a clinical development company dedicated to translating state-of-the art science into novel medicines for treating diseases that currently pose great challenges to patients, their families and their physicians. The company leverages the skills and extensive experience of its team and the financial commitment of its investors to focus on a small family of orphan diseases. Imago BioSciences translates unique insights into high impact transformative therapies that alter the natural history of disease allowing patients to live longer, disease-free lives. Imago BioSciences was founded in 2012 and is based in Redwood City, California.